Compare PLTK & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLTK | MLAB |
|---|---|---|
| Founded | 2010 | 1982 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 808.6M | 719.9M |
| IPO Year | 2020 | 1995 |
| Metric | PLTK | MLAB |
|---|---|---|
| Price | $2.48 | $137.94 |
| Analyst Decision | Hold | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $4.24 | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 82.1K |
| Earning Date | 11-05-2026 | 11-09-2026 |
| Dividend Yield | ★ 3.91% | 0.46% |
| EPS Growth | N/A | ★ 436.11 |
| EPS | 0.08 | ★ 1.25 |
| Revenue | ★ $2,755,400,000.00 | N/A |
| Revenue This Year | $1.43 | $2.30 |
| Revenue Next Year | N/A | $4.41 |
| P/E Ratio | ★ $32.06 | $112.36 |
| Revenue Growth | ★ 8.08 | N/A |
| 52 Week Low | $1.89 | $69.51 |
| 52 Week High | $4.42 | $144.35 |
| Indicator | PLTK | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 60.48 | 60.37 |
| Support Level | $2.10 | $119.77 |
| Resistance Level | $2.98 | $144.35 |
| Average True Range (ATR) | 0.15 | 5.95 |
| MACD | 0.07 | 1.30 |
| Stochastic Oscillator | 68.79 | 79.82 |
Playtika Holding Corp is engaged in developing mobile games. Some of its games include Board Kings, House of Fun, Poker Heat, Slotomania, and Bingo Blitz. The company has built live game operations services and a proprietary technology platform to support its portfolio of games. It derives revenue from the sale of virtual items associated with online games. Geographically, the group has a business presence in the USA, EMEA, APAC, and Other regions of which key revenue is derived from the USA. The company offers both Mobile and Web-based platforms.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.